tiprankstipranks
Trending News
More News >
Mediwound (MDWD)
NASDAQ:MDWD
US Market
Advertisement

Mediwound (MDWD) Earnings Dates, Call Summary & Reports

Compare
433 Followers

Earnings Data

Report Date
Mar 12, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.57
Last Year’s EPS
-0.36
Same Quarter Last Year
Based on 6 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 20, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call highlighted significant advancements in clinical trials and manufacturing capabilities, as well as strong revenue growth. However, these were offset by increased operating losses and uncertainties related to government contracts and clinical trial timelines.
Company Guidance
During the third quarter of 2025, MediWound provided comprehensive guidance on its strategic objectives and financial performance. The company is advancing its EscharEx program, targeting $831 million in potential annual peak sales, driven by positive market access assessments and expected shifts in reimbursement policies. MediWound is also progressing with the VALUE Phase III trial for venous leg ulcers, aiming for 216 patients across 40 sites, and plans to start a diabetic foot ulcer study in the second half of 2026. NexoBrid's manufacturing capacity has expanded sixfold, enhancing MediWound's ability to meet global demand. Financially, the company reported a 23% year-over-year revenue increase to $5.4 million for the quarter, supported by higher development services revenue and an improved gross margin of 16.5%. Operating loss increased to $6.5 million, while net loss improved to $2.7 million. The company strengthened its balance sheet with $60 million in cash after completing a $30 million equity financing, positioning it well for future growth.
Progress in EscharEx VLU Trial
Enrollment in the VALUE Phase III trial for EscharEx, targeting venous leg ulcers, is advancing with strong support from previous Phase II results. The trial's co-primary endpoints include complete debridement and wound closure.
Expansion of NexoBrid Manufacturing
MediWound completed the commissioning of an expanded NexoBrid manufacturing facility, increasing production capacity by six times, aiming to meet rising global demand.
Financial Strengthening
The balance sheet was strengthened with $30 million of equity financing, increasing cash reserves to $60 million as of September 30, 2025.
Revenue Growth
Revenue for the third quarter was $5.4 million, a 23% increase year-over-year, driven by higher development services revenue.
NexoBrid U.S. Market Performance
NexoBrid achieved record quarterly revenue in the U.S., with a 38% year-over-year increase and 26% sequential growth.

Mediwound (MDWD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MDWD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 12, 2026
2025 (Q4)
-0.57 / -
-0.36
Nov 20, 2025
2025 (Q3)
-0.81 / -0.24
-0.9875.51% (+0.74)
Aug 14, 2025
2025 (Q2)
-0.57 / -1.23
-0.68-80.88% (-0.55)
May 21, 2025
2025 (Q1)
-0.66 / -0.07
-1.0593.33% (+0.98)
Mar 19, 2025
2024 (Q4)
-0.58 / -0.36
-0.19-89.47% (-0.17)
Nov 26, 2024
2024 (Q3)
-0.48 / -0.98
-0.24-308.33% (-0.74)
Aug 14, 2024
2024 (Q2)
-0.42 / -0.68
0.1-780.00% (-0.78)
May 29, 2024
2024 (Q1)
-0.41 / -1.05
-0.44-138.64% (-0.61)
Mar 21, 2024
2023 (Q4)
-0.26 / -0.19
-1.1883.90% (+0.99)
Nov 21, 2023
2023 (Q3)
-0.44 / -0.24
-0.9173.63% (+0.67)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

MDWD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 20, 2025
$17.86$16.86-5.60%
Aug 14, 2025
$18.75$18.57-0.96%
May 21, 2025
$20.87$19.89-4.70%
Mar 19, 2025
$19.27$18.28-5.14%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Mediwound (MDWD) report earnings?
Mediwound (MDWD) is schdueled to report earning on Mar 12, 2026, Before Open (Confirmed).
    What is Mediwound (MDWD) earnings time?
    Mediwound (MDWD) earnings time is at Mar 12, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is MDWD EPS forecast?
          MDWD EPS forecast for the fiscal quarter 2025 (Q4) is -0.57.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis